Prevail Innovative Wealth Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-109,562
Closed -$1.66M 205
2025
Q2
$1.66M Sell
109,562
-1,611
-1% -$23.5K 0.37% 90
2025
Q1
$1.6M Buy
111,173
+4,319
+4% +$66K 0.43% 76
2024
Q4
$1.62M Sell
106,854
-7,704
-7% -$124K 0.47% 70
2024
Q3
$1.88M Buy
114,558
+26,062
+29% +$427K 0.57% 60
2024
Q2
$1.45M Buy
+88,496
New +$1.42M 0.51% 75

Other funds holding BCAT

Prevail Innovative Wealth Advisors's BCAT Position: Q3 2025 in Review

Prevail Innovative Wealth Advisors sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2025, closing a stake of 109,562 shares — an estimated $1.66M sold.

Prevail Innovative Wealth Advisors first reported a position in BCAT in Q2 2024 and held it in 5 quarters. The position peaked at $1.88M in Q3 2024. 94 funds tracked by Wall St. Rank hold BCAT as of Q3 2025.

  • Prevail Innovative Wealth Advisors reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
  • Prevail Innovative Wealth Advisors sold 109,562 BlackRock Capital Allocation Term Trust shares in Q3 2025, an estimated $1.66M.
  • Prevail Innovative Wealth Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and held it in 5 quarters.
  • Prevail Innovative Wealth Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.88M in Q3 2024.
  • 94 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2025.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.